Outlook is neutral, with stock confined to a range of ±4%
Strategy has +58% ROI potential and 6% overvalued
Outlook is neutral, with stock confined to a range of ±3%
Strategy has +54% ROI potential and 9% overvalued
UNH Unitedhealth Group Common (De)330.67-2.82 (-0.9%)